Description
Glycenor M is a combination medication containing 5 mg of Empagliflozin and 500 mg of Metformin Hydrochloride, used to manage type 2 diabetes mellitus in adults. Empagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, promoting glucose excretion through urine. Metformin is a biguanide that decreases hepatic glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity. Together, they help lower blood sugar levels, support weight loss, and may reduce the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
.jpg)
Change Language